Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors | Docwire News
This provides rationale for the clinical evaluation of defactinib and avutometinib in the treatment of melanoma metastases.
Related Articles
Upadacitinib Shows Promise for Hidradenitis Suppurativa | Docwire News
Treatment with the drug demonstrated lesion and pain control in moderate to severe disease.
New Data on Terlipressin Presented at DDW 2025 | Docwire News
Peter Richardson and George Wan of Mallinckrodt discussed data on terlipressin for hepatorenal syndrome–acute kidney injury (HRS-AKI) presented at Digestive Disease Week 2025.
Study Data Bolster Quercetin Treatment of Fanconi Anemia in Young Persons | Docwire News
Reactive oxygen species levels decreased and patients with evident bone marrow failure showed hematological response.
Is Plasma Mannose-Binding Lectin a Clue to Higher VTE Risk? | Docwire News
Investigation of a HUNT Study cohort found elevated plasma MBL levels to be associated with increased risk for future VTE.
Changing the Conversation: Obesity as Chronic Disease | Docwire News
Obesity is a chronic, complex disease driven by biology, not just behavior—effective care requires empathy and support.
Mepolizumab Approved as Add-On Treatment for Chronic Obstructive Pulmonary Disease | Docwire News
The drug significantly reduced the annual rate of moderate or severe exacerbations in eosinophilic phenotypes.
Effect of As-Needed BP Medications on AKI Risk Among Hospitalized Veterans | Docwire News
A study examined whether treatment of in-hospital blood pressure elevations increases the risk of acute kidney injury (AKI) and other adverse outcomes.
Hemophilia B Gene Therapy Shows Promise as Long-Term Treatment | Docwire News
Fidanacogene elaparvovec gene therapy is a safe and effective treatment for patients with hemophilia B, research shows.
GPP Relief: Spesolimab Cuts Flares and Boosts Quality of Life | Docwire News
Symptomatic benefits of treatment on the severity of pustules, erythema, and scaling were observed.
Factors Associated With Low Allopurinol Adherence | Docwire News
Researchers examined factors associated with adherence to the urate-lowering therapy (ULT) allopurinol, a cornerstone of gout management.